San Francisco, CA, United States of America

Perfuse Therapeutics, Inc.

Calculating rank

USPTO Granted Patents = 5

Trademarks = 1

Forward Citations = 8

Loading Chart...

5 inventors (with patents filed for the assignee):

Sevgi Gurkan (5 out of 5 patents)

David M Floyd (3 out of 27 patents)

Zhongli Ding (2 out of 9 patents)

4. Angela Dawn Glendenning (2 out of 2 patents)

5. Cheng-Wen Lin (2 out of 3 patents)

5 patents: Sort by Forward Citations

1. 12735411 - Compositions for treatment of ocular diseases (2026-09-15),

2. 12622894 - Pharmaceutical compositions and intravitreal drug delivery systems for the treatment of ocular diseases (2026-05-12),

3. 11873279 - Compositions for treatment of ocular diseases (2024-01-16),

4. 11786510 - Pharmaceutical compositions and intravitreal drug delivery systems for the treatment of ocular diseases (2023-10-17),

5. 11738007 - Treatment of glaucoma using endothelin receptor antagonists (2023-08-29),

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

5 Patents

#764 in San Francisco, CA

#12,079 in California

#51,669 in US

San Francisco, CA, United States of America

Perfuse Therapeutics, Inc.

Forward Citations = 8

5 inventors:

Sevgi Gurkan (5 out of 5 patents)

David M Floyd (3 out of 27 patents)

Zhongli Ding (2 out of 9 patents)

4. Angela Dawn Glendenning (2 out of 2 patents)

5. Cheng-Wen Lin (2 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Perfuse Therapeutics, Inc.. Retrieved from https://idiyas.com/company/perfuse-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]